INDIANAPOLIS--(BUSINESS WIRE)--Marcadia Biotech, today announced it has signed a licensing agreement that will give it the rights to develop and market drug candidates in the therapeutic area of metabolic diseases. The license agreement is with Indiana University Research and Technology Corp. (IURTC) and the company signed a separate sponsored research agreement with IU Bloomington.
